Noom Med vs Wellorithm: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Noom Med and Wellorithm are tied at 7.4/10. Noom Med is more affordable at $69/mo vs $147/mo. Choose Noom Med for users who want a tiered entry into glp-1 care — from $69 bra. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side comparison of Noom Med and Wellorithm covering pricing, scores, medication types, insurance, and more to help you decide.
Noom Med
#28 of 46Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.
Visit Noom MedWellorithm
#30 of 46Telehealth platform for compounded semaglutide and tirzepatide that uniquely offers BOTH injectable and oral dissolving tablet formats, paired with a 10% weight-loss guarantee that refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle, with a documented address listed in Berlin, Germany.
Visit Wellorithm| Feature | Noom Med | Wellorithm |
|---|---|---|
| Our Score | 7.4/10 | 7.4/10 |
| Starting Price | $69/mo | $147/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | Yes | No |
| Best For | Users who want a tiered entry into GLP-1 care — from $69 branded telehealth to a full $349/mo medication + coaching program, with a new Microdose option at $99-149 | Cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers |
| Ranking | #28 | #30 |
Pros & Cons Compared
Noom Med
Pros
- +Tiered 2026 entry — $69/mo branded telehealth tier lets users start with just medication access and the coaching app
- +New Microdose GLP-1Rx program ($99-149/mo) — low-dose GLP-1 + biomarker monitoring for sensitive users
- +Insurance accepted for qualifying plans — can significantly reduce out-of-pocket costs on brand-name meds
- +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology
Cons
- −Tiered pricing creates confusion — $69, $99-149, or $149-349 depending on tier
- −Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
- −Medication costs on the $69 tier are out-of-pocket — the low tier price is just the platform
- −App coaching still requires real engagement — skip-prone users waste the behavioral value
Wellorithm
Pros
- +Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats — semaglutide and tirzepatide each in two formats — broader format menu than most compounded-only platforms
- +10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
- +Competitive entry pricing — $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
- +2-minute qualification quiz, virtual consultation, 24/7 support availability claimed
- +23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment — verify on independent third-party sources before relying on it)
- +Spring promotion advertised at $147 with free shipping included
Cons
- −Founding year, corporate ownership, and named prescribers are NOT publicly disclosed — the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients
- −49 states only — service is unavailable in Louisiana and outside the United States
- −28-day recurring billing cycle with payments non-refundable once processed — strict cancellation policy and no proration for partial months
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; FDA does not review compounded medications for safety, effectiveness, or manufacturing quality
- −Weight-loss guarantee terms are restrictive: requires verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval — only fees actually paid are refundable, baseline payments remain non-refundable
- −Two different affiliate landing pages (campaign-7 and qoroxapi/lead.php direct route) with different funnel structures suggest the platform tests multiple lead-capture flows, which can create inconsistent post-click experiences
Our Verdict
Noom Med and Wellorithm are closely matched with identical scores of 7.4/10. If budget is your priority, Noom Med starts at $69/mo compared to Wellorithm's $147/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Noom Med offers both brand-name and compounded medications, giving you more flexibility. Choose Noom Med if you want: users who want a tiered entry into glp-1 care — from $69 branded telehealth to a full $349/mo medication + coaching program, with a new microdose option at $99-149. Choose Wellorithm if you want: cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers.